Last reviewed · How we verify
NBP615
At a glance
| Generic name | NBP615 |
|---|---|
| Sponsor | SK Bioscience Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity and Safety Study of NBP615 in Healthy Female (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NBP615 CI brief — competitive landscape report
- NBP615 updates RSS · CI watch RSS
- SK Bioscience Co., Ltd. portfolio CI